Author/Authors :
Hsia، نويسنده , , Judith and Jablonski، نويسنده , , Kathleen A. and Rice، نويسنده , , Madeline Murguia and Sabatine، نويسنده , , Marc S. and Zabalgoitia، نويسنده , , Miguel and Maggioni، نويسنده , , Aldo and Cuddy، نويسنده , , Thomas E. and Domanski، نويسنده , , Michael J. and Geller، نويسنده , , Nancy L. and Flaker، نويسنده , , Greg and Solomon، نويسنده , , Scott and Omland، نويسنده , , Torbjّrn، نويسنده ,
Abstract :
Although sudden cardiac death (SCD) has been extensively studied in patients with coronary artery disease (CAD) and low ejection fraction, prediction of SCD among individuals with preserved left ventricular systolic function is less well understood. We randomized 8,290 patients with stable CAD with preserved left ventricular systolic function to trandolapril or placebo in a secondary coronary prevention trial, and we used Cox proportional hazards models to identify independent baseline predictors of SCD during 4.8 year follow-up (median). Using a risk scoring algorithm based on simple clinical characteristics, we were able to distinguish individuals at higher risk for SCD. Independent determinants of SCD included age (p <0.001), current angina pectoris (p = 0.002), ejection fraction >40% to <50% (as opposed to >50%) (p <0.001), and diuretic (p <0.001) and digitalis use (p <0.001). Negative predictors included having prior coronary revascularization (p = 0.01) and being female (p = 0.02) or Caucasian (p = 0.006). Trandolapril neither increased nor decreased SCD. Thus, among patients with stable CAD with preserved left ventricular systolic function receiving current standard-of-care including coronary revascularization, clinical characteristics can identify individuals at higher risk for SCD.